GMED vs. EW

In the year-to-date period, GMED achieves a -28.45% return, which is significantly lower than EW's 5.66% return. Over the past 10 years, GMED has underperformed EW with an annualized return of 8.80%, while EW has yielded a comparatively higher 13.59% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GMED Sharpe Ratio is -0.30, which is comparable to the EW Sharpe Ratio of -0.27. The chart below compares the historical Sharpe Ratios of GMED and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither GMED nor EW has paid dividends to shareholders.

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum EW drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for GMED and EW.

Globus Medical, Inc. (GMED) has a higher volatility of 28.22% compared to Edwards Lifesciences Corporation (EW) at 5.02%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Globus Medical, Inc. and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.